Lipocalin 2 expression is associated with aggressive features of endometrial cancer

BACKGROUND: Increased expression of lipocalin 2 (LCN2) has been observed in several cancers. The aim of the present study was to investigate LCN2 in endometrial cancer in relation to clinico-pathologic phenotype, angiogenesis, markers of epithelial-mesenchymal transition (EMT), and patient survival....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mannelqvist, Monica, Stefansson, Ingunn M, Wik, Elisabeth, Kusonmano, Kanthida, Raeder, Maria B, Øyan, Anne M, Kalland, Karl-Henning, Moses, Marsha A, Salvesen, Helga B, Akslen, Lars A
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3493289/
https://ncbi.nlm.nih.gov/pubmed/22559235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-169
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados